Chinese traditional medicine has been listed in the United States Pharmacopoeia dozens of drugs are under review

Source: On August 7, 2014, the national health and Family Planning Commission held a press conference Zhang Boli, President of the Chinese Academy of traditional Chinese medicine, said that China's traditional Chinese medicine standards have been listed in the US pharmacopoeia Now there are dozens of drugs under review by the US Pharmacopoeia Committee, and it is estimated that they will be included in the US pharmacopoeia in recent years Zhang Boli pointed out that China's major special projects also paid close attention to the research and development of new Chinese medicine and the internationalization of Chinese medicine, and also deployed such topics In particular, it supports the registration and research of new Chinese medicine in European and American countries, that is, the clinical evaluation of traditional Chinese medicine according to the standards of European and American countries Now there are nearly seven drugs in clinical research in the United States Among them, compound Danshen dropping pill, Xuezhikang and Fuzheng Huayu capsule have completed the second phase of clinical research, some have carried out the third phase of clinical research, some are preparing to carry out the third phase of clinical research Guizhi Fuling Jiaowan in the second phase of clinical research, the progress is relatively smooth At the same time, registration research has also been carried out in the European Union, among which Di'ao Xinxuekang has completed the registration work, and several drugs are in progress, and it is expected to achieve registration success in the past year or two This batch of drugs is registered in European and American countries, which improves the influence of traditional Chinese medicine Zhang Boli stressed that there are some Chinese standards for traditional Chinese medicine, such as Salvia miltiorrhiza, which has been listed in the US pharmacopoeia This is the first Chinese medicine listed in the US pharmacopoeia in our country There are still dozens of drugs under review by the USP Committee, and it is estimated that they will be included in USP in recent years, which is also a significant progress The standard of Chinese medicinal materials has been included in the USP, and they will also require botanical drugs according to this standard, which provides a basis for more of our drugs to enter the United States In general, major projects have played a positive role in promoting the modernization and internationalization of traditional Chinese medicine, and made some progress